Liquid-filled hard capsule formulations offer unique options for the manufacture and dosing of highly potent actives.
Highly potent active pharmaceutical ingredients (HPAPIs) are an increasing portion of pharma and biotech pipelines. Because of their highly potent nature and the low dose for these compounds, occupational exposure and dose uniformity can be make the development pathway more difficult. Read Lonza’s whitepaper on how liquid-filled hard capsules can improve a HPAPI compound’s development pathway.
Offered Free by: Lonza
See All Resources from: Lonza